Precision Biosciences (DTIL) Change in Receivables (2018 - 2026)
Precision Biosciences (DTIL) reported Change in Receivables of $4.0 million for Q1 2026, up 1877.78% year-over-year from $202247.2 in Q1 2025, and up 100100.0% quarter-over-quarter from -$4000.0 in Q4 2025.
Precision Biosciences (DTIL) Change in Receivables (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Change in Receivables data on file, last reported at $4.0 million in Q1 2026.
- Change in Receivables for Q1 2026 came in at $4.0 million, up 1877.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.0 million (up 1135.23% YoY), and the FY2025 annual result was -$229000.0, up 65.92% from the prior year.
- Change in Receivables grew to $4.0 million in Q1 2026 per DTIL's latest filing, from -$4000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $4.0 million in Q1 2026 and troughed at -$49.8 million in Q3 2022.
- A 5-year average of -$3.1 million and a median of -$19000.0 in 2024 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2023 and 2026: Change in Receivables plunged 51940.0% in 2023, then surged 1877.78% in 2026.
- A 5-year view of Change in Receivables shows it stood at $5000.0 in 2022, then sank by 51940.0% to -$2.6 million in 2023, then soared by 101.58% to $41000.0 in 2024, then plunged by 109.76% to -$4000.0 in 2025, then surged by 100100.0% to $4.0 million in 2026.
- Business Quant data shows DTIL's Change in Receivables at $4.0 million in Q1 2026, -$4000.0 in Q4 2025, and $4000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - | 4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | -4,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Mar 31, 2025 | -225,000.00 |
| Mar 31, 2025 | -225,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | -19,000.00 |
| Sep 30, 2024 | -19,000.00 |
| Jun 30, 2024 | -183,000.00 |
| Jun 30, 2024 | -183,000.00 |
| Mar 31, 2024 | -511,000.00 |
| Mar 31, 2024 | -511,000.00 |
| Dec 31, 2023 | -2.59 Mn |
| Dec 31, 2023 | -2.59 Mn |